Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists

Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists

The therapeutic use of A<sub>2A</sub> adenosine receptor (AR) antagonists for the treatment of neurodegenerative disorders, such as Parkinson and Alzheimer diseases, is a very promising approach. Moreover, the potential therapeutic role of A<sub>2A</sub> AR antagonists to avo...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Flavia Varano, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta
Natura:	Articolo
Lingua:	English
Pubblicazione:	MDPI AG 2020-07-01
Serie:	Pharmaceuticals
Soggetti:	G protein-coupled receptors adenosine receptors adenosine A<sub>2A</sub> receptor ligands thiazolo[5,4-<i>d</i>]pyrimidines
Accesso online:	https://www.mdpi.com/1424-8247/13/8/161

Documenti analoghi

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A<sub>1</sub> and A<sub>2A</sub> Receptors, and Efficacy in Animal Models of Depression
di: Flavia Varano, et al.
Pubblicazione: (2021-07-01)

A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
di: Stefania Gessi, et al.
Pubblicazione: (2021-09-01)

The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
di: Lucia Squarcialupi, et al.
Pubblicazione: (2017-01-01)

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
di: Andrea Spinaci, et al.
Pubblicazione: (2022-01-01)

How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
di: Akihisa Mori, et al.
Pubblicazione: (2021-08-01)

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
di: Daniela Catarzi, et al.
Pubblicazione: (2022-04-01)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A<sub>2B</sub> Receptor Binding Affinity
di: Marcel Lindemann, et al.
Pubblicazione: (2021-05-01)

Pharmacology of Adenosine Receptors: Recent Advancements
di: Fabrizio Vincenzi, et al.
Pubblicazione: (2023-09-01)

Adenosine A<sub>2A</sub> Receptors Shut Down Adenosine A<sub>1</sub> Receptor-Mediated Presynaptic Inhibition to Promote Implementation of Hippocampal Long-Term Potentiation
di: Cátia R. Lopes, et al.
Pubblicazione: (2023-04-01)

Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes
di: Silvia Pasquini, et al.
Pubblicazione: (2020-04-01)

A Comparison in the Use of the Crystallographic Structure of the Human A<sub>1</sub> or the A<sub>2A</sub> Adenosine Receptors as a Template for the Construction of a Homology Model of the A<sub>3</sub> Subtype
di: Enrico Margiotta, et al.
Pubblicazione: (2019-02-01)

Caffeine for Prevention of Alzheimer’s Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?
di: Stefania Merighi, et al.
Pubblicazione: (2023-06-01)

Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A<sub>2A</sub> receptor-dependent manner: A<sub>2A</sub> receptor blockade prevents BDNF release and proliferation of microglia
di: Gomes Catarina, et al.
Pubblicazione: (2013-01-01)

Adenosine Receptors Profile in Fibromuscular Dysplasia
di: Claire Guiol, et al.
Pubblicazione: (2022-11-01)

Hypoxia Depresses Synaptic Transmission in the Primary Motor Cortex of the Infant Rat—Role of Adenosine A<sub>1</sub> Receptors and Nitric Oxide
di: Isabella Zironi, et al.
Pubblicazione: (2022-11-01)

Adenosine A<sub>2A</sub> receptor activation reduces recurrence and mortality from <it>Clostridium difficile</it> infection in mice following vancomycin treatment
di: Li Yuesheng, et al.
Pubblicazione: (2012-12-01)

Development of Bicyclo[3.1.0]hexane-Based A<sub>3</sub> Receptor Ligands: Closing the Gaps in the Structure–Affinity Relationships
di: Jan Phillip Lemmerhirt, et al.
Pubblicazione: (2022-03-01)

Adenosine A<sub>2A</sub> Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ<sub>1–42</sub> to Model Early Alzheimer’s Disease
di: Cátia R. Lopes, et al.
Pubblicazione: (2023-07-01)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
di: Rafael Franco, et al.
Pubblicazione: (2021-10-01)

Intraglomerular Monocyte/Macrophage Infiltration and Macrophage–Myofibroblast Transition during Diabetic Nephropathy Is Regulated by the A<sub>2B</sub> Adenosine Receptor
di: Ángelo Torres, et al.
Pubblicazione: (2020-04-01)

Current Understanding of the Role of Adenosine Receptors in Cancer
di: Katharigatta Narayanaswamy Venugopala, et al.
Pubblicazione: (2024-07-01)

Two-Dimensional NMR Spectroscopy of the G Protein-Coupled Receptor A<sub>2A</sub>AR in Lipid Nanodiscs
di: Canyong Guo, et al.
Pubblicazione: (2023-07-01)

Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y<sub>12</sub> Receptor Antagonists
di: Nina Wolska, et al.
Pubblicazione: (2019-12-01)

Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent Manner
di: Nina Wolska, et al.
Pubblicazione: (2020-07-01)

Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A<sub>1</sub> and A<sub>3</sub> Adenosine Receptors
di: Luke J. Hamilton, et al.
Pubblicazione: (2023-06-01)

Plasma A<sub>2A</sub>R Measurement Can Help Physicians Identify Patients Suspected of Coronary Chronic Syndrome: A Pilot Study
di: Franck Paganelli, et al.
Pubblicazione: (2022-08-01)

Allosteric Antagonism of the A<sub>2A</sub> Adenosine Receptor by a Series of Bitopic Ligands
di: Zhan-Guo Gao, et al.
Pubblicazione: (2020-05-01)

“Dual Anta-Inhibitors” of the A<sub>2A</sub> Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
di: Andrea Spinaci, et al.
Pubblicazione: (2023-01-01)

Presynaptic Purinergic Modulation of the Rat Neuro-Muscular Transmission
di: Adel E. Khairullin, et al.
Pubblicazione: (2023-10-01)

The Pharmacological Potential of Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson’s Disease
di: Akihisa Mori, et al.
Pubblicazione: (2022-04-01)

Synthesis, Antibacterial and Antitubercular Activities of Some 5H-Thiazolo[3,2-a]pyrimidin-5-ones and Sulfonic Acid Derivatives
di: Dong Cai, et al.
Pubblicazione: (2015-09-01)

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
di: Silvia Pasquini, et al.
Pubblicazione: (2022-10-01)

Adenosine A<sub>2A</sub>Receptors in Substance Use Disorders: A Focus on Cocaine
di: Karolina Wydra, et al.
Pubblicazione: (2020-06-01)

Synthesis and Structure of 6-Acetyl-2-Arylhydrazone Derivatives of Thiazolo[3,2-<i>a</i>]Pyrimidine
di: Artem S. Agarkov, et al.
Pubblicazione: (2023-08-01)

The Adenosine A<sub>2B</sub> Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments
di: Helen J. Knowles
Pubblicazione: (2019-06-01)

Design and Synthesis of 2,6-Disubstituted-4′-Selenoadenosine-5′-<em>N</em>,<em>N</em>-Dimethyluronamide Derivatives as Human A<sub>3</sub> Adenosine Receptor Antagonists
di: Hongseok Choi, et al.
Pubblicazione: (2021-04-01)

Radiosynthesis and In Vitro Evaluation of [<sup>11</sup>C]tozadenant as Adenosine A<sub>2A</sub> Receptor Radioligand
di: Swen Humpert, et al.
Pubblicazione: (2024-02-01)

A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
di: Fabrizio Vincenzi, et al.
Pubblicazione: (2020-12-01)

Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome
di: Matilde S. Rodrigues, et al.
Pubblicazione: (2022-02-01)

Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy
di: Mercedes Fernandez, et al.
Pubblicazione: (2023-10-01)